Further insight into the mode of action of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). (Q45099160)

9 December 2017

title

Further insight into the mode of action of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). (English)

1 reference

9 December 2017

Gessner W

1

1 reference

9 December 2017

Brossi A

series ordinal

2

1 reference

9 December 2017

Shen RS

series ordinal

3

1 reference

9 December 2017

Abell CW

series ordinal

4

1 reference

9 December 2017

language of work or name

English

0 references

publication date

1 April 1985

1 reference

9 December 2017

1 reference

9 December 2017

volume

183

1 reference

9 December 2017

issue

2

1 reference

9 December 2017

page(s)

345-348

1 reference

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2885%2980807-3

Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2885%2980807-3

Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2885%2980807-3

Potential bioactivation pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2885%2980807-3

Pargyline Prevents MPTP-Induced Parkinsonism in Primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2885%2980807-3

Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2885%2980807-3

Studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2885%2980807-3

Oxidation of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by monoamine oxidases A and B and suicide inactivation of the enzymes by MPTP

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2885%2980807-3

Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2885%2980807-3

Uptake of MPP(+) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2885%2980807-3

Effects of N-substituted phenyltetrahydropyridines on cerebral high-affinity synaptosomal uptake of dopamine and other monoamines in several mammalian species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2885%2980807-3

MPTP neurotoxicity: an overview and characterization of phases of toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2885%2980807-3

Metabolism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse liver preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2885%2980807-3

Inhibition of dopamine uptake by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a cause of parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2885%2980807-3

10.1016/0014-5793(85)80807-3

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference